| Patents for C07C 259 - Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups (4,411) |
|---|
| 03/15/2006 | EP0956859B1 Antioxidizing composition for scavenging free radicals, pharmaceutical composition comprising the same, and process for preparing the same |
| 03/15/2006 | CN1245381C Phenylglycine derivatives |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/09/2006 | US20060052608 Kinase inhibitors; antiproliferative agents; anticancer agents; psoriasis; restenosis |
| 03/09/2006 | US20060052599 HDAC inhibitor |
| 03/08/2006 | EP1482924A4 Cathepsin cysteine protease inhibitors |
| 03/08/2006 | EP1235791A4 A multistage process for the preparation of highly pure deferoxamine mesylate salt |
| 03/08/2006 | EP1039902B1 Inhibitors of gap junction communication |
| 02/28/2006 | US7005450 2-amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2006 | CA2574035A1 Histone deacetylase inhibitors |
| 02/21/2006 | US7001905 Substituted diarylamines as MEK inhibitors |
| 02/21/2006 | CA2184691C L-n6-(1-iminoethyl)lysine derivatives useful as nitric oxide synthase inhibitors |
| 02/16/2006 | CA2573509A1 Histone deacetylase inhibitors |
| 02/16/2006 | CA2573369A1 Inhibitors of histone deacetylase |
| 02/14/2006 | CA2248598C Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors |
| 02/09/2006 | CA2575928A1 Compounds for inhibiting copper-containing amine oxidases and uses thereof |
| 02/08/2006 | EP1622865A2 Novel bioisosteres of actinonin |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 01/26/2006 | WO2001085170A9 Peptide deformylase inhibitors |
| 01/25/2006 | EP1618087A2 Antibacterial agents |
| 01/25/2006 | CN1238323C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds |
| 01/12/2006 | WO2006003068A2 Alpha-amino acid derivatives with antiinflammatory activity |
| 01/12/2006 | WO2006002506A1 Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases |
| 01/12/2006 | US20060009658 Preparation of hydroxamic acids from esters in solution and on the solid phase |
| 01/12/2006 | US20060009525 Hydroxamic acids and acyl hydroxamines as NAALADase inhibitors |
| 01/12/2006 | CA2572597A1 Hydroxyamate-containing materials for the inhibition of matrix metalloproteinases |
| 01/11/2006 | EP1613305A1 Crystalline n-formyl hydroxylamine compounds |
| 01/11/2006 | EP1385814A4 Enantiomerically selective cyclopropanation |
| 01/11/2006 | CN1720034A Methods of inducing terminal differentiation |
| 01/11/2006 | CN1235925C Solid phase synthesing method of aldehyde, ketonic, oxime, amine and isohydroximic acid compound |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/05/2006 | US20060004078 N-hydroxyformamidine derivatives |
| 01/04/2006 | EP1611088A2 Hydroxamates as therapeutic agents |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 12/29/2005 | US20050288369 Novel n-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 12/29/2005 | DE19748040B4 Carbonsäurederivate, Verfahren zu ihrer Herstellung und pharmazeutische Präparate, die diese Verbindungen enthalten Carboxylic acid derivatives, processes for their preparation and pharmaceutical preparations containing these compounds |
| 12/28/2005 | EP1399416A4 Peptide deformylase inhibitors |
| 12/28/2005 | EP0918514B1 Triaryl methane compounds for the treatment of cancer, actinic keratosis and kaposi's sarcoma |
| 12/28/2005 | CN1714079A Mandelic acid derivatives |
| 12/27/2005 | CA2305463C Aminobutanoic acid derivatives |
| 12/27/2005 | CA2290506C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as mek inhibitors |
| 12/22/2005 | WO2005053610A3 Diamine and iminodiacetic acid hydroxamic acid derivatives |
| 12/22/2005 | US20050283019 selective monoamine oxidase B inhibitors; neurodegenerative diseases; Alzheimer's Disease |
| 12/22/2005 | US20050282882 Diamines as modulators of chemokine receptor activity |
| 12/14/2005 | EP1603891A1 New amide derivatives of 2,2,3,3-tetramethylcyclopropane carboxylic acid |
| 12/14/2005 | EP1263712B1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 12/13/2005 | US6974836 Diamines as modulators of chemokine receptor activity |
| 12/13/2005 | CA2227237C N-(aroyl)glycine hydroxamic acid derivatives and related compounds |
| 12/08/2005 | US20050272815 Compounds and compositions for delivering active agents |
| 12/07/2005 | CN1705642A Novel N-hydroxy thiourea, urea and amide compounds and the pharmaceutical compositions comprising the same |
| 12/06/2005 | US6972300 Compounds and compositions for delivering active agents |
| 11/30/2005 | CN1703396A Novel propargylether derivatives for controlling phytopathogenic microorganisms |
| 11/30/2005 | CN1229508C Mineral collector compositions of fatty hydroxamic acid in admixture with oil and process of making same |
| 11/29/2005 | US6969748 Metal complexes of iminohydroxamic acids |
| 11/24/2005 | WO2005039498A3 Methods of treating cancer with hdac inhibitors |
| 11/24/2005 | US20050261504 Process for preparing intermediates |
| 11/23/2005 | EP1598067A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors |
| 11/23/2005 | EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 11/22/2005 | US6967220 antibiotics; treating respiratory system disorders; n-hydroxy benzyl formamide derivatives |
| 11/17/2005 | WO2005107762A2 Certain chemical entities, compositions, and methods |
| 11/17/2005 | US20050256333 4-(3-(2,6-Dimethoxybenzyloxy)phenyl)-4-oxobutyric acid or derivatives for treatment of insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis or arteriosclerosis |
| 11/17/2005 | US20050256199 2-Amino-2-alkyl-4 hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 11/17/2005 | CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 11/02/2005 | EP1278719B1 Naphthamide neurokinin antagonists for use as medicaments |
| 11/01/2005 | US6960685 histone deacetylase; antiproliferative agents; psoriasis, cancer; N-Hydroxy-2-(4-Isopropyl-phenylcarbamoyl)-methoxy)-acetamide |
| 11/01/2005 | US6960614 Oxygenated esters of 4-lodo phenylamino benzhydroxamic acids |
| 11/01/2005 | US6960355 Modified amino acid compounds useful in delivery of active agents |
| 10/27/2005 | US20050240023 Cathepsin cysteine protease inhibitors |
| 10/26/2005 | EP1587784A2 Bisaminophenyl-based curatives and amidine-based curatives and cure accelerators for perfluoroelastomeric compositions |
| 10/26/2005 | CN1224598C Naphthalene derivatives |
| 10/25/2005 | CA2304974C 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 10/20/2005 | WO2005097747A1 Histone deacetylase inhibitor prodrugs |
| 10/20/2005 | US20050234131 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof |
| 10/20/2005 | CA2561617A1 Histone deacetylase inhibitor prodrugs |
| 10/19/2005 | EP1585757A2 Peptide deformylase inhibitors |
| 10/19/2005 | CN1684945A Process for preparing intermediates |
| 10/18/2005 | CA2294171C N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 10/12/2005 | EP1583736A1 Carbamic acid compounds comprising an ester or ketone linkage as hdac inhibitors |
| 10/12/2005 | EP1385837B1 Tricyclic alkylhydroxamates, their preparation and their use as cell proliferation inhibitors |
| 10/12/2005 | CN1681775A N-hydroxyformamidine derivative |
| 10/06/2005 | WO2005055928A3 Zn2+ -chelating motif-tethered short -chain fatty acids as a novel class of histone deacetylase inhibitors |
| 10/06/2005 | US20050222412 Antibiotic; bactericides |
| 10/06/2005 | US20050222013 Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy |
| 10/05/2005 | CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 10/04/2005 | US6951889 7-acetamidinyl derivatives |
| 10/04/2005 | CA2238275C Metalloproteinase inhibitors |
| 09/29/2005 | US20050215799 reacting aryl/heteroaryl triflate/halide with carbon monoxide and N-hydroxysuccinimide in solvent in presence of palladium catalyst and base |
| 09/29/2005 | DE102004032265A1 Use of a substance, which inhibits body odor causing gram-positive anaerobic cocci, in a cosmetic deodarant- or antitranspirant-composition to reduce the body odor |
| 09/22/2005 | WO2005087710A1 Aminophenylpropanoic acid derivative |
| 09/22/2005 | US20050207996 Use of osteopontin in dental formulations |
| 09/22/2005 | CA2560111A1 Aminophenylpropanoic acid derivative |
| 09/21/2005 | CN1219753C Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 09/20/2005 | US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 09/14/2005 | EP1572645A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex |
| 09/14/2005 | EP1250317B1 Bis-basic compounds for use as tryptase inhibitors, method for producing the same and their use as medicaments |
| 09/07/2005 | CN1217922C 2-amino-2-alkyl-4-hexenoic and hexynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/06/2005 | CA2217479C Derivatives of phenoxyethylamine having a high affinity for 5-ht1a receptor, their preparation procedure, their application as medications and pharmaceutical compounds containing them |
| 09/01/2005 | US20050192338 Process for the preparation of Ropinirole |
| 08/31/2005 | EP1568689A1 Process for the preparation of the 2-oxoindole derivative, Ropinirole |